Sustained Collaboration of National and Regional Cancer Funders
The Sustained Collaboration of National and Regional Cancer Funders under Horizon Europe brings together national, regional and charity funders across Northern, Southern, Central, Eastern and Western Europe to issue at least four joint transnational calls in translational cancer research aligned with the EU Cancer Mission and Europe’s Beating Cancer Plan.
Eligibility Criteria:
-
Consortium of public and private research funders from at least three different European regions (North, South, East, West, Central)
-
Partners must include national or regional agencies, foundations or charities
-
Demonstrated capacity to pool and leverage financial resources for joint calls
-
Commitment to FAIR data and open-science principles for tools and models
Funding Details:
-
Type of Action: HORIZON-CSA (Lump Sum Grant)
-
Total EU Contribution: ~5 000 000 EUR
-
Number of Grants: 1
-
Grant Model: Single-stage lump sum
Deadline:
Applications must be submitted via the EU Funding & Tenders Portal by 16 September 2025, 17:00 (Brussels time).
Where to Apply & More Info:
-
EU Funding & Tenders Portal: Search for topic HORIZON-MISS-2025-02-CANCER-01
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023